Amgen Presents Positive Results In First Phase III For Denosumab At San Antonio
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm plans to file BLA in late 2008, early 2009 for post-menopausal osteoporosis and treatment induced osteopenia.